10-K Decoder · All companies

Niagen Bioscience, Inc.

NAGE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$129M$99.6M+29.9%
Operating income$16.3M$7.73M+111%
Net income$17.4M$8.55M+103%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026

$Q3 2026Year earlierChange
Revenue$27.2M$34.0M−20.0%
Operating income−$1.60M$4.20M
Net income−$1.20M$4.60M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Niagen Bioscience's revenue in FY2025?
$129M in FY2025 (Fiscal year ended Dec 31, 2025), +29.9% vs $99.6M a year earlier, per its 10-K filed Mar 2026.
Was Niagen Bioscience profitable in FY2025?
Yes: net income was $17.4M and operating income $16.3M in FY2025.
What was Niagen Bioscience's revenue in Q3 2026?
$27.2M (−20.0% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.